Labcorp Holdings Inc's shares surged to a record $339.78 on Thursday, extending gains after the company reported second-quarter earnings and revenue that exceeded analyst projections.
The company posted adjusted earnings of $4.99 per share for the quarter, up from $4.34 in the same period a year earlier and above the $4.79 forecast by analysts. Revenue increased 5.8% to $3.73 billion, driven by steady growth across its operations. The stock was trading at $339.63 at midday, just 1% below its 52-week high and reflecting a 23.22% gain over the past year.
Labcorp's year-to-date performance has also been robust, with a cumulative return of 34.52%. The company's shares, listed under the ticker `LH`, were up 0.24% at $336.54 in late trading on August 26, according to market data.
The earnings beat follows an upward revision by 11 analysts who adjusted their estimates higher for the upcoming period. Labcorp also raised its full-year outlook, citing stronger-than-expected earnings and sustained revenue growth. The improved guidance contributed to the stock's rally toward record territory.
In a separate development, Megan D. Bailey, Executive Vice President and President of Central Laboratories and International, announced her resignation, effective September 4, 2026. The company did not provide an immediate replacement or further details regarding the leadership transition.
InvestingPro analysis suggested the stock may be overvalued relative to its fair value estimate, while offering additional insights through eight ProTips and a full research report. The company's shares have been closely monitored amid broader market sentiment and sector-specific performance trends.
